• Users Online: 10
  • Home
  • Print this page
  • Email this page

Ahead of Print policy

Articles published online under the Ahead of Print model are considered published and can be cited and quoted using the DOI as the reference source. Wolters Kluwer Medknow has a policy that changes will not be made after publication of an article without following accepted procedures for making corrections to the scientific record.

 Coming soon

1.  Uric Acid Levels in Patients on Antituberculosis Drugs in The South West Region of Cameroon
2.  Enhancing antimycobacterial activity of Isoniazid and Rifampicin incorporated Norbornene nanoparticles
3.  Identification of Potential Inhibitors for Mycobacterial UDP-Galactopyranose Mutase Enzyme, A Novel Drug Target through in Silico Approach
4.  Estimation of pyrazinamidase activity using a cell-free in vitro synthesis of PncA and its association with pyrazinamide susceptibility in Mycobacterium tuberculosis
5.  Mycobacterium abscessus subsp. abscessus lung disease: drug susceptibility testing in sputum culture negative conversion
6.  Utilization of molecular and conventional methods for the identification of nontuberculous mycobacteria isolated from different water sources
7.  Detection of multidrug resistant tuberculosis from stored DNA samples: a multicenter study
8.  In-vitro activity of seven hospital biocides against Mycobacterium abscessus: Implications for patients with cystic fibrosis (CF)
1.  Mycobacterium chelonae osteomyelitis presenting as a mycobacterial spindle cell pseudotumour
2.  Pneumoperitoneum During Treatment of Abdominal Tuberculosis in a non-HIV Patient: Natural Progression or Paradoxical Worsening?
3.  Reactive Perforating Leprosy, Erythema Multiforme-Like Reactions, Sweet’s Syndrome-Like Reactions As Atypical Clinical Manifestations Of Type 2 Leprosy Reaction
1.  Patients at high risk of tuberculosis recurrence